Esperion Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Esperion Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2018 to Q2 2024.
  • Esperion Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 189M shares, a 72.8% increase year-over-year.
  • Esperion Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 103M shares, a 55.3% increase from 2022.
  • Esperion Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 66.4M shares, a 130% increase from 2021.
  • Esperion Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 28.9M shares, a 5.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 189M +79.5M +72.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 169M +90.8M +116% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 103M +36.7M +55.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 112M +44.1M +65% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 109M +46M +72.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 78.4M +17.5M +28.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 66.4M +37.5M +130% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 67.8M +41.4M +156% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 63.2M +37M +141% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 61M +35M +135% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 28.9M +2.02M +7.51% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-21
Q3 2021 26.5M -1.38M -4.94% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 26.2M -1.44M -5.21% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 26M -1.53M -5.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 26.9M -488K -1.78% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-23
Q3 2020 27.8M +659K +2.42% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 27.7M +697K +2.58% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 27.5M +676K +2.52% Jan 1, 2020 Mar 31, 2020 10-K 2021-02-23
Q4 2019 27.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 27.2M Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 27M +182K +0.68% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 26.8M +238K +0.89% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q2 2018 26.8M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 26.6M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.